EBioMedicine 115: 105684
Los efectos pueden variar segn la persona, la alimentacin y el nivel de actividad fsica
Jump to your state: AL, AK, AZ, AR, CA, CO, CT, DE, DC, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY How we built this table Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes
Disrupting the putative binding sites for -globin repressors like BCL11A to induce HbF production will be an attractive therapeutic strategy for both -thalassemic and SCD patients (Masuda et al., 2016
Biomed J Sci&Tech Res 7(2)-2018
Yoo HJ, Park KY, Park KS, Ahn KJ, Min KW, Park JH, Chang SA, Cha BS, Kim DJ, Kim YS, Oh TK, Chon S, Nam-Goong IS, Kim MJ, Kim HS, Choi YS, Ahn YH, Lee S, Baik SH